| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Executive Officer
1 company
Irish Jian is a See Remarks at MGX. Recent filings cover 0 purchases and 5 sales. Those positions are worth an estimated $435K at current prices.
Our model assigns Irish Jian a middling insider score of 64/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +26.0%.
Irish Jian's largest disclosed position is in MGX as See Remarks, worth about $435K. The recent filings there lean toward selling, a net 15,471 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | MGX Metagenomi Therapeutics, Inc. | See Remarks | Sell | 2,140 | $1.16 | $2,478.98 | -0.6% | - | - | |
| Jun 5, 2026 | MGX Metagenomi Therapeutics, Inc. | See Remarks | Sell | 3,737 | $1.30 | $4,854.36 | -1.0% | - | - | |
| Dec 5, 2025 | MGX Metagenomi, Inc. | Chief Executive Officer | Sell | 1,602 | $1.77 | $2,838.58 | -0.3% | -9.6% | - | |
| Sep 5, 2025 | MGX Metagenomi, Inc. | Chief Executive Officer | Sell | 1,602 | $1.81 | $2,899.62 | -0.5% | -6.3% | - | |
| Jun 6, 2025 | MGX Metagenomi, Inc. | See Remarks | Sell | 6,390 | $1.75 | $11,182.50 | -2.0% | +2.9% | -26.0% |